🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Replimune Group, Inc.

REPL Healthcare
$8.69 +$4.01 (85.68%)
Market Cap: $717.56 M
Gurus Holding
5
Popularity Rank
#1773
% of Shares Held
2.03%
Net Activity (Q1 2026)
+$2.2 M

Guru Ownership Trend

Guru Analysis for Replimune Group, Inc. (REPL)

Replimune Group, Inc. (REPL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $14.56 M.

Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $2.2 M net inflow during the quarter.

Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 5.8%.

Key Holders

Recent Activity Breakdown (Q1 2026)

+$4.33 M
Total Buy Value
New Buys 2
Additions 0
-$2.13 M
Total Sell Value
Reductions 3
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
5
Net Buyers
2

FAQs for Replimune Group, Inc. (REPL)

Major holders include Jefferies Group ($5.46 M), Renaissance Technologies (RenTech) ($2.92 M), Louis Moore Bacon ($2.38 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.68 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.2 M, with 2 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited REPL. The total reported sell value was $2.13 M.

Yes, 2 managers opened new positions in REPL, and 0 increased their existing holdings. The total reported buy value was $4.33 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.04% Reduce 0.0% 714,225 $5.46 M Q1 2026
0.00% Reduce -5.8% 381,453 $2.92 M Q1 2026
0.05% New Buy 311,124 $2.38 M Q1 2026
0.00% New Buy 255,495 $1.95 M Q1 2026
0.00% Reduce -4.4% 13,188 $100,888 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form